Anderson LW - Search Results

1

Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.

Anderson LW, Chen TL, Colvin OM, Grochow LB, Collins JM, Kennedy MJ, Strong JM. Anderson LW, et al. Clin Cancer Res. 1996 Sep;2(9):1481-7. Clin Cancer Res. 1996. PMID: 9816324 Clinical Trial.

2

Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood.

Anderson LW, Ludeman SM, Colvin OM, Grochow LB, Strong JM. Anderson LW, et al. J Chromatogr B Biomed Appl. 1995 May 19;667(2):247-57. doi: 10.1016/0378-4347(95)00036-i. J Chromatogr B Biomed Appl. 1995. PMID: 7663697 Free article.

3

Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.

Chen TL, Kennedy MJ, Anderson LW, Kiraly SB, Black KC, Colvin OM, Grochow LB. Chen TL, et al. Among authors: anderson lw. Drug Metab Dispos. 1997 May;25(5):544-51. Drug Metab Dispos. 1997. PMID: 9152592

4

In vitro glucuronidation of D-23129, a new anticonvulsant, by human liver microsomes and liver slices.

McNeilly PJ, Torchin CD, Anderson LW, Kapetanovic IM, Kupferberg HJ, Strong JM. McNeilly PJ, et al. Among authors: anderson lw. Xenobiotica. 1997 May;27(5):431-41. doi: 10.1080/004982597240424. Xenobiotica. 1997. PMID: 9179986

5

Gas chromatographic-mass spectrometric method for routine monitoring of 5-fluorouracil in plasma of patients receiving low-level protracted infusions.

Anderson LW, Parker RJ, Collins JM, Ahlgren JD, Wilkinson D, Strong JM. Anderson LW, et al. J Chromatogr. 1992 Oct 23;581(2):195-201. doi: 10.1016/0378-4347(92)80272-r. J Chromatogr. 1992. PMID: 1452610

6

Isolation, structural determination, and biological activity of 6 alpha-hydroxytaxol, the principal human metabolite of taxol.

Harris JW, Katki A, Anderson LW, Chmurny GN, Paukstelis JV, Collins JM. Harris JW, et al. Among authors: anderson lw. J Med Chem. 1994 Mar 4;37(5):706-9. doi: 10.1021/jm00031a022. J Med Chem. 1994. PMID: 7907372

7

Cellular pharmacology of DUP-785, a new anticancer agent.

Anderson LW, Strong JM, Cysyk RL. Anderson LW, et al. Cancer Commun. 1989;1(6):381-7. doi: 10.3727/095535489820875101. Cancer Commun. 1989. PMID: 2562006

8

An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype.

Weaver JL, Contrera JF, Rosenzweig BA, Thompson KL, Faustino PJ, Strong JM, Ellison CD, Anderson LW, Prasanna HR, Long-Bradley PE, Lin KK, Zhang J, Sistare FD. Weaver JL, et al. Among authors: anderson lw. Toxicol Pathol. 1998 Jul-Aug;26(4):532-40. doi: 10.1177/019262339802600409. Toxicol Pathol. 1998. PMID: 9715512

9

Oxime derivatives of the intermediary oncostatic metabolites of cyclophosphamide and ifosfamide: synthesis and deuterium labeling for applications to metabolite quantification.

Ludeman SM, Shulman-Roskes EM, Wong KK, Han SY, Anderson LW, Strong JM, Colvin OM. Ludeman SM, et al. Among authors: anderson lw. J Pharm Sci. 1995 Apr;84(4):393-8. doi: 10.1002/jps.2600840403. J Pharm Sci. 1995. PMID: 7629726 Free article.

10

Glutamine and glutamate: automated quantification and isotopic enrichments by gas chromatography/mass spectrometry.

Anderson LW, Zaharevitz DW, Strong JM. Anderson LW, et al. Anal Biochem. 1987 Jun;163(2):358-68. doi: 10.1016/0003-2697(87)90236-3. Anal Biochem. 1987. PMID: 2889398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters